It is a chemicals private limited company based in Jail Road, Kerala, India, established in 2018.
2018 | Jail Road, Kerala, India | ActiveKestrel Pharmaceuticals Private Limited, a active private limited company, was established on 29 November 2018 in Jail Road, Kerala, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239KL2018PTC055732. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.95 M.
It upholds a compliant status. Its leadership includes Nisha Prajeesh (Director), Manju Krishna (Director), Abhilash Thankappan (Director). Past directors included Nisha Prajeesh, Manju Krishna, Abhilash Thankappan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Room No. 18/1084 G4, 3Rd Floor Meyon Building, Jail Road, Kerala, 673004.
U24239KL2018PTC055732
055732
29 November 2018
₹1.00 M
₹0.95 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Kestrel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nisha Prajeesh | Director | 20 Feb 2020 | Current |
| Manju Krishna | Director | 12 Mar 2019 | Current |
| Abhilash Thankappan | Director | 15 Oct 2019 | Current |
| Priyesh Thena Parambil | Managing Director | 29 Nov 2018 | Current |
| Vysakh Santhoshkumar Nair | Director | 29 Nov 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2019 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kestrel Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 15.22% decrease. The company also saw a substantial improvement in profitability, with a 39.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 77.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kestrel Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kestrel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kestrel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kestrel Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kestrel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Kestrel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Progress on Nisha Prajeesh was appointed as a Director was appointed as a Director on 20 Feb 2020 & has been associated with this company since 5 years 9 months . was documented.
Progress on Abhilash Thankappan was appointed as a Director was appointed as a Director on 15 Oct 2019 & has been associated with this company since 6 years 1 month . was documented.
Manju Krishna was appointed as a Director was appointed as a Director on 12 Mar 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.
Progress on Priyesh Thena Parambil was appointed as a Managing Director was appointed as a Managing Director on 29 Nov 2018 & has been associated with this company since 7 years 5 days . was documented.
The CIN of Kestrel Pharmaceuticals Private Limited is U24239KL2018PTC055732.
Kestrel Pharmaceuticals Private Limited is headquartered at Room No. 18/1084 G4, 3Rd Floor Meyon Building, Jail Road, Kerala, 673004.
Kestrel Pharmaceuticals Private Limited was incorporated on 29 November 2018.
The current directors of Kestrel Pharmaceuticals Private Limited are
The primary industry of Kestrel Pharmaceuticals Private Limited is Chemicals.
Kestrel Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kestrel Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.95 M.
The compliance status of Kestrel Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX